ArticleInternational journal of clinical and experimental pathology2018

PRRX1 drives tamoxifen therapy resistance through induction of epithelial-mesenchymal transition in MCF-7 breast cancer cells.

Jiaojiao Dong et al.PubMed ↗Full text ↗

No numbers read from the abstract.